CMG Pharmaceutical Co., Ltd.
KOE: 058820.KQ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- KOSDAQ
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Joohyung Lee
- Employees
- 273
- Headquarters
- Seoul, South Korea
- IPO year
- 2001
- Market cap
- ₩234.5B
- Website
- https://www.cmgpharma.co.kr
Loading 058820…
Loading profile data…Frequently asked questions about 058820
What does CMG Pharmaceutical Co., Ltd. (058820.KQ) do?
CMG Pharmaceutical Co., Ltd., a pharmaceutical company, develops and sells oral thin film (OTF) pharmaceuticals in South Korea. It offers Tadalafil OTF products for erectile dysfunction; Entecavir OTF products to treat hepatitis type B; Aripiprazole OTF products for schizophrenia; and Montelukast OTF products to treat asthma and allergic rhiniti...
Where does 058820.KQ trade?
CMG Pharmaceutical Co., Ltd. (058820.KQ) trades on the KOSDAQ.
What sector is 058820.KQ in?
CMG Pharmaceutical Co., Ltd. (058820.KQ) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of CMG Pharmaceutical Co., Ltd.?
Joohyung Lee is the chief executive officer of CMG Pharmaceutical Co., Ltd. (058820.KQ).
Where is CMG Pharmaceutical Co., Ltd. headquartered?
CMG Pharmaceutical Co., Ltd. is headquartered in South Korea.
Does 058820.KQ pay a dividend?
CMG Pharmaceutical Co., Ltd. (058820.KQ) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 058820.KQ go public?
CMG Pharmaceutical Co., Ltd. (058820.KQ) completed its initial public offering in 2001.